Ikarian Capital’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.48M Buy
217,700
+117,700
+118% +$4.58M 0.91% 31
2026
Q1
$3.81M Buy
+100,000
New +$2.58M 0.31% 71
2022
Q2
Sell
-25,700
Closed -$199K 170
2022
Q1
$199K Sell
25,700
-142,200
-85% -$5.55M 0.03% 167
2021
Q4
$14.2M Hold
167,900
2.12% 12
2021
Q3
$16.1M Buy
167,900
+95,600
+132% +$8.83M 1.13% 17
2021
Q2
$6.72M Buy
+72,300
New +$6.94M 0.54% 52

Other funds holding KOD

Ikarian Capital's KOD Position: Q2 2026 in Review

Ikarian Capital reduced its Kodiak Sciences (KOD) stake by 16% in Q2 2026, selling an estimated $8.02M and leaving 1,059,730 shares worth $41.3M. The position accounts for 4.45% of the portfolio, ranked #4.

Ikarian Capital first reported a position in KOD in Q1 2022 and has held it in 15 quarters since. The position peaked at $48.3M in Q1 2026. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Ikarian Capital held 1,059,730 shares of Kodiak Sciences worth $41.3M as of Q2 2026.
  • Ikarian Capital sold 206,065 Kodiak Sciences shares in Q2 2026, an estimated $8.02M.
  • Kodiak Sciences made up 4.45% of Ikarian Capital's portfolio in Q2 2026, its #4 holding.
  • Ikarian Capital first reported a position in Kodiak Sciences in Q1 2022 and has held it in 15 quarters since.
  • Ikarian Capital's Kodiak Sciences position peaked at $48.3M in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.